Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echocardiograms

Paul A. Grayburn, James L. Weiss, Terrence C. Hack, Elizabeth Klodas, Joel S. Raichlen, Manni A. Vannan, Allan L. Klein, Dalane W. Kitzman, Steven G. Chrysant, Jerald L. Cohen, David Abrahamson, Elyse Foster, Julio E. Perez, Gerard P. Aurigemma, Julio A. Panza, Michael H. Picard, Benjamin F. Byrd, Douglas S. Segar, Stuart A. Jacobson, David J. SahnAnthony N. Demaria

Research output: Contribution to journalArticlepeer-review

100 Scopus citations

Fingerprint Dive into the research topics of 'Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echocardiograms'. Together they form a unique fingerprint.

Medicine & Life Sciences